CEO of Alexion Pharmaceuticals Inc. (ALXN, Financial) Leonard Bell sells 1,294 shares of ALXN on 07/16/2010 at an average price of $51.08 a share.
Alexion Pharmaceuticals Inc. has a market cap of $4.52 billion; its shares were traded at around $50.4 with a P/E ratio of 50.91 and P/S ratio of 11.67.
ALXN is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Columbia Wanger of Columbia Wanger Asset Management, George Soros of Soros Fund Management LLC, Pioneer Investments, Jim Simons of Renaissance Technologies LLC, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors.
Alexion Pharmaceuticals Inc. has a market cap of $4.52 billion; its shares were traded at around $50.4 with a P/E ratio of 50.91 and P/S ratio of 11.67.
ALXN is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Columbia Wanger of Columbia Wanger Asset Management, George Soros of Soros Fund Management LLC, Pioneer Investments, Jim Simons of Renaissance Technologies LLC, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors.
CEO Recent Trades:
- Sell: CEO Leonard Bell sold 1,078 shares of ALXN stock on 07/12/2010 at the average price of 51.91. Leonard Bell owns at least 869,795 shares after this. The price of the stock has decreased by 2.91% since.
CFO Recent Trades:
- Sell: SVP & CFO Vikas Sinha sold 486 shares of ALXN stock on 07/12/2010 at the average price of 51.91. Vikas Sinha owns at least 53,821 shares after this. The price of the stock has decreased by 2.91% since.
- Sell: SVP & CFO Vikas Sinha sold 20,000 shares of ALXN stock on 03/25/2010 at the average price of 55. Vikas Sinha owns at least 54,307 shares after this. The price of the stock has decreased by 8.36% since.
- Sell: SVP & CFO Vikas Sinha sold 30,000 shares of ALXN stock on 02/22/2010 at the average price of 50.01. Vikas Sinha owns at least 54,307 shares after this. The price of the stock has increased by 0.78% since.
Directors and Officers Recent Trades:
- Buy: Director Andreas Rummelt bought 5,000 shares of ALXN stock on 05/10/2010 at the average price of 52.6. Andreas Rummelt owns at least 8,892 shares after this. The price of the stock has decreased by 4.18% since.
- Buy: Director Ruedi E Waeger bought 3,000 shares of ALXN stock on 05/03/2010 at the average price of 55.1. Ruedi E Waeger owns at least 24,054 shares after this. The price of the stock has decreased by 8.53% since.
- Sell: SVP Commercial Ops, Americas David Hallal sold 238 shares of ALXN stock on 07/12/2010 at the average price of 51.91. David Hallal owns at least 6,616 shares after this. The price of the stock has decreased by 2.91% since.
- Sell: EVP & Head of R&D Stephen P Squinto sold 249 shares of ALXN stock on 07/12/2010 at the average price of 51.91. Stephen P Squinto owns at least 35,205 shares after this. The price of the stock has decreased by 2.91% since.
- Sell: SVP & General Counsel Thomas I H Dubin sold 249 shares of ALXN stock on 07/12/2010 at the average price of 51.91. Thomas I H Dubin owns at least 10,183 shares after this. The price of the stock has decreased by 2.91% since.
